Debra Karvois

Debra brings more than 25 years’ experience in drug development from J&J and TAP Pharmaceuticals. She played a leading role in the Xarelto® development program, and she brings extensive experience in NDA and sNDA submissions with the FDA and applications for marketing authorization globally.

Debra holds a MS in Clinical Chemistry from Old Dominion University.